EPISODE · May 8, 2025 · 18 MIN
Current State of Biotech, Market Pressure Points, Obesity and PD-1/VEGF
from WTR Healthcare Happenings · host Joe Brunetto
Tim Gerdeman and Do Kim discuss the current state of biotech, what brought us here, and how the rest of year may look for the group. They also review recent market-shaping events in the obesity space and progress of the Keytruda-busting PD-1/VEGF bispecifics.
What this episode covers
Tim Gerdeman and Do Kim discuss the current state of biotech, what brought us here, and how the rest of year may look for the group. They also review recent market-shaping events in the obesity space and progress of the Keytruda-busting PD-1/VEGF bispecifics.
NOW PLAYING
Current State of Biotech, Market Pressure Points, Obesity and PD-1/VEGF
No transcript for this episode yet
Similar Episodes
No similar episodes found.